NCT07217236View on ClinicalTrials.gov

Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG

NARecruitingINTERVENTIONAL
Enrollment

11,492

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Artificial Intelligence (AI)Cardiac Implantable Electrical DevicesConduction Disorder of the Heart
Interventions
DIAGNOSTIC_TEST

AI-ECG driven ECG monitoring

Participants identified as high-risk for CIED implantation by the AI-ECG system will receive a continuous cardiac rhythm monitor for up to 7 days.

Trial Locations (1)

Unknown

RECRUITING

Tri-Service General Hospital, Taipei

All Listed Sponsors
lead

National Defense Medical Center, Taiwan

OTHER